DrugDashboards

NU-DERM system NORMAL-DRY SKIN TRANSFORMATION TRIAL

Hydroquinone, Homosalate, Octisalate, and Zinc Oxide · Kit · Obagi Cosmeceutical Llc

NDC 62032-0532-07 · 1 KIT in 1 CARTON * 59 mL in 1 BOTTLE, PLASTIC * 57 g in 1 BOTTLE, PLASTIC * 28 g in 1 BOTTLE, PLASTIC * 85 g in 1 TUBE * 59 mL in 1 BOTTLE, PLASTIC * 28 g in 1 BOTTLE, PLASTIC · UNAPPROVED DRUG OTHER · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
—
TE code
—
Approval date
—
Patents / exclusivity
—

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Hydroquinone, Homosalate, Octisalate, and Zinc Oxide (Kit)

LabelerStrengthFirst seenLast seen
Obagi Cosmeceutical LlcJul 15, 2026Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "NU-DERM system NORMAL-DRY SKIN TRANSFORMATION TRIAL — NDC 62032-0532-07," retrieved September 3, 2026, https://drugdashboards.com/drug/62032053207.

Free to cite with attribution — see how the data is put together.